x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Oprah"s Weight Loss Dilemma: The Ozempic

Inception Point Ai

Join us on "The Oprah Ozempic Odyssey," where we explore the intriguing world of weight loss through the lens of Oprah Winfrey"s recent remarks about the weight loss drug, Ozempic. Dive into the heated debate surrounding the use of weight loss drugs, and discover the pros and cons of Ozempic as we break down its potential benefits and side effects. Through thoughtful discussions and a touch of humor, we help you navigate this complex topic, providing insights and considerations to make informed

health & fitness medicine

All Episodes

4:32

Ozempic and Weight Loss Drugs Reshape Health...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2026/03/07

Ozempic and similar weight loss drugs have dominated health headlines again this week, and much of the conversation is circling around how these medications are reshaping expectations about body size, long term health, and even celebrity image. Ozempic, whose generic name is semaglutide, is part of a class of drugs called glucagon like peptide one receptor agonists that were first approved to help people with type two diabetes manage blood sugar. In recent years doctors have also prescribed them for

en

2:56

GLP One Drugs Transform Weight Loss and Diabetes...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2026/03/04

The landscape of weight loss medications is evolving rapidly. Just this week, Health Canada approved an expanded indication for Ozempic, semaglutide injection, to reduce the risk of major adverse cardiovascular events in adults with type two diabetes who have established cardiovascular disease or chronic kidney disease. This approval comes based on positive outcomes from multiple clinical trials including SUSTAIN 6, PIONEER 6, FLOW and SOUL, marking an important advancement in how these medications

en

2:51

Novo Nordisk Slashes Wegovy and Ozempic Prices Up to...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2026/02/28

The weight loss drug market is undergoing a dramatic transformation this week as Novo Nordisk announced major price cuts for its popular medications Ozempic and Wegovy. Starting January 2027, the Danish pharmaceutical company will reduce prices by up to 50 percent for Wegovy and 35 percent for Ozempic, with both medications selling for 675 dollars per month. This announcement reflects intensifying competition in the GLP-1 drug market, where Eli Lilly's Mounjaro and Zepbound have been aggressively

en

2:39

Novo Nordisk Cuts Ozempic and Wegovy Prices Up to...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2026/02/25

Novo Nordisk announced on Tuesday that it plans to cut the list prices of its blockbuster weight-loss and diabetes drugs Ozempic and Wegovy by up to fifty percent starting January first, twenty twenty-seven. The Danish company stated that various doses of these medications, which contain the active ingredient semaglutide, will drop to six hundred seventy-five dollars per month. This represents a fifty percent reduction for Wegovy and a thirty-five percent cut for Ozempic, with the same price

en

2:18

Ozempic MDL Reaches 3000 Cases Over Side Effects...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2026/02/21

Recent developments in the Ozempic multidistrict litigation highlight growing concerns over side effects from the popular weight loss drug. Lawsuit Information Center reports that as of early February 2026, the MDL includes over three thousand pending cases, with a status conference on February tenth addressing case management, plaintiff fact sheets, and discovery timelines. Plaintiffs allege that Novo Nordisk failed to adequately warn about risks like gastroparesis, or stomach paralysis, and

en

2:36

GLP-1 Weight Loss Drugs Ozempic and Mounjaro Show 11...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2026/02/18

Recent Cochrane reviews commissioned by the World Health Organization show that blockbuster weight loss drugs like Ozempic deliver substantial results. According to ScienceDaily reporting on February 11, these GLP-1 drugs, including semaglutide in Ozempic and tirzepatide in Mounjaro, lead to average weight losses of 11 to 16 percent over one to two years in people with obesity, far outperforming placebos in trials with thousands of participants. Tirzepatide achieved about 16 percent reduction after

en

3:02

GLP-1 Weight Loss Drugs Show Promise: Semaglutide and...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2026/02/14

Recent news highlights ongoing developments in weight loss treatments like Ozempic, with fresh insights from clinical reviews and patient experiences. On February 11, 2026, Cochrane reviews commissioned by the World Health Organization analyzed GLP-1 drugs including semaglutide, sold as Ozempic and Wegovy. These studies, drawing from dozens of trials with tens of thousands of participants, show semaglutide leads to an average weight loss of about 11 percent after six to 18 months when paired with

en

2:19

Ozempic and Wegovy Weight Loss: Benefits, Risks, and...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2026/02/11

Recent research from the University of Cambridge highlights a key concern with popular weight-loss drugs like Ozempic and Wegovy. These medications sharply reduce appetite, leading to calorie intake dropping by sixteen to thirty-nine percent, which drives effective weight loss for people with obesity. However, experts from University College London and the University of Cambridge warn that many users lack proper nutrition guidance, risking muscle loss of up to forty percent of total weight shed and

en

2:52

GLP-1 Drugs Like Ozempic Transform Weight Loss...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2026/02/07

In the past week, weight loss drugs like Ozempic, Wegovy, and Mounjaro have reshaped global conversations on obesity, marking 2026 as a potential turning point. Firstpost reports that these GLP-1 drugs, originally developed for type two diabetes, trigger significant weight loss by curbing appetite, leading to falling obesity rates in the United States for the first time since the 1980s. One in eight Americans now uses these medications, sparking changes across industries. Supermarkets see snack

en

2:37

Novo Nordisk CagriSema Outperforms Ozempic in Phase...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2026/02/04

Novo Nordisk's new drug CagriSema has outperformed Ozempic in a recent Phase III trial for type 2 diabetes patients, according to Clinical Trials Arena. In the REIMAGINE 2 study, CagriSema reduced HbA1c levels by 1.91 percentage points and achieved 14.2 percent weight loss after 68 weeks, compared to 1.76 percentage points and 10.2 percent with Ozempic. No weight loss plateau occurred with CagriSema, and 43 percent of patients lost at least 15 percent of their body weight. Martin Holst Lange, Novo

en

2:48

Oprah Endorses GLP-1 Drugs for Weight Loss as...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2026/01/31

Oprah Winfrey has been candid this week about her ongoing use of GLP-1 medications like those containing semaglutide, the active ingredient in Ozempic, for weight management. In recent interviews promoting her new book Enough: Your Health, Your Weight, and What It's Like to be Free, co-authored with Yale professor Dr. Ania M. Jastreboff, she shared that she started these weekly injections in 2023 and views them as a lifelong tool, much like blood pressure medicine. Oprah told People magazine she

en

2:58

GLP-1 Medications Transform Weight Loss Treatment as...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2026/01/28

The landscape of weight loss treatment in America is shifting dramatically as glucagon-like peptide-one receptor agonists, or GLP-1s, continue to dominate conversations about obesity management. According to a Pew Research Center report from January 2026, thirteen states now cover GLP-1s for obesity treatment under Medicaid, though this represents progress tempered by significant setbacks. California, New Hampshire, Pennsylvania, and South Carolina stopped covering these medications as of January

en

2:24

Oprah Reveals Ozempic Weight Regain After Stopping...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2026/01/24

Oprah Winfrey shared striking insights this week on her experience with Ozempic, a popular drug known as semaglutide for type two diabetes and weight management. On the Today Show on January 21, 2026, the media icon revealed she gained 20 pounds after stopping the medication for nearly a year. She wanted to prove she could maintain her weight through discipline alone, including hiking regularly and exercising up to two hours a day, six days a week. But the weight returned quickly, leading her to

en

2:39

Oprah Winfrey Opens Up About GLP-1 Medications for...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2026/01/21

Oprah Winfrey has been candid this week about her experiences with GLP-1 medications like Ozempic for weight loss. According to RadarOnline on January 16, she dropped about 50 pounds two and a half years ago after starting the drug but gained back 20 pounds when she stopped taking it after six months. She shared on The View and her podcast that she once blamed herself for her weight, feeling shame from constant food noise in her head, but now views obesity as a disease beyond personal control, much

en

2:47

Health Canada Approves First Daily GLP One Pill...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2026/01/17

Health Canada approved the first glucagon-like peptide one daily pill, Rybelsus, on Monday for adults with type two diabetes who face high risks of heart disease. This semaglutide pill, made by the same company behind injectable Ozempic and Wegovy, aims to improve blood sugar levels alongside diet and exercise while cutting chances of heart attacks, strokes, or death from cardiovascular events. Company trials with over nine thousand six hundred fifty patients showed it lowered those risks compared

en

2:54

GLP-1 Weight Loss Drugs Cut Grocery Spending 5...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2026/01/14

Recent research from Cornell University reveals that weight-loss drugs like Ozempic and Wegovy are significantly reducing how much Americans spend on food. According to the study published in the Journal of Marketing Research, households cut grocery spending by an average of 5.3 percent within six months of starting these GLP-1 receptor agonist medications, with higher-income families seeing drops over 8 percent. Fast-food and coffee shop spending fell by about 8 percent too. The biggest declines

en

3:13

Ozempic and GLP-1 Medicines Show Promise but...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2026/01/10

Ozempic and similar glucagon like peptide 1 medicines remain at the center of the weight loss conversation this week, as new research and renewed celebrity attention highlight both their promise and their limits. According to a January report from the American Society for Metabolic and Bariatric Surgery, scientists reviewing records from more than fifty thousand patients found that people who had bariatric surgery lost about five times more weight over two years than those using weekly glucagon like

en

3:54

Ozempic Weight Loss Drugs Show Promise but Surgery...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2026/01/08

This week, new research and policy news are reshaping the conversation around Ozempic and other weight loss drugs, while Oprah Winfrey continues to influence how many listeners think about these medications. On the scientific front, a major analysis presented by the American Society for Metabolic and Bariatric Surgery compared real world outcomes for more than fifty thousand people using glucagon like peptide one drugs such as semaglutide, the active ingredient in Ozempic, with those who underwent

en

4:09

Ozempic and Weight Loss: The Transformative Medical...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2025/11/29

The weight loss medication debate has taken a fascinating turn as public figures continue to grapple with the decision to use drugs like Ozempic and Wegovy. Oprah Winfrey, one of America's most influential personalities, has found herself at the center of this conversation, and her stance reveals the complex relationship many people have with these powerful pharmaceutical tools. For years, Oprah publicly resisted using Ozempic, stating that she felt taking the medication would be taking the easy way

en

2:39

Oprah Reveals Ozempic Weight Loss Journey Breaking...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2025/11/26

In the past week, the conversation around weight loss medications, particularly Ozempic, has intensified following new statements from Oprah Winfrey. Oprah recently addressed her own experience with the drug, clarifying her previous comments and responding to public speculation. According to recent reports, Oprah revealed that she lost forty pounds using Ozempic, a medication originally developed for type two diabetes but now widely used off-label for weight loss. Her admission comes after months of

en

63 results

Similar Podcasts

Доктор Тройняшкин

Доктор Тройняшкин

Доктор Тройняшкин

Доктор Тройняшкин

The Dry Eye Treatment PODCAST

Dry Eye Treatment

The Dry Eye Treatment PODCAST

Dry Eye Treatment

Différent et alors ?

PATRICK SULAY